(−)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana, prevents diabetes and hyperlipidemia by regulation of glucose transporter 4 and AMP-activated protein kinase phosphorylation in high-fat-fed mice

International Journal of Molecular Sciences

Volumn 16, Issue 10, 2015, Pages 24983-25001

  Shih, Chun Ching ^a   Wu, Jin Bin ^b   Jian, Jia Ying ^a   Lin, Cheng Hsiu ^c   Ho, Hui Ya ^d  

^a CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c FENG YUAN HOSPITAL   (Taiwan)

^d Jen Li Biotech Co Ltd   (Taiwan)

Author keywords

AMP activated protein kinase phosphorylation; Davallia formosana; Diabetes; Glucose transporter 4; Hypertriglyceridemia

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; EPICATECHIN 3 O BETA DEXTRO ALLOPYRANOSIDE; FENOFIBRATE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOENOLPYRUVATE; ROSIGLITAZONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOSE BLOOD LEVEL;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DAVALLIA FORMOSANA; DIABETES MELLITUS; DIETARY INTAKE; DRUG DOSE COMPARISON; DRUG PURIFICATION; DYSLIPIDEMIA; ENZYME PHOSPHORYLATION; EXTRACTION; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; MEDICINAL PLANT; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; WEIGHT GAIN; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GENETICS; HYPERLIPIDEMIAS; MALE; METABOLISM; PHOSPHORYLATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FENOFIBRATE; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; MALE; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PLANTS, MEDICINAL; THIAZOLIDINEDIONES;

EID: 84944755072     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms161024983     Document Type: Article

References (58)

1. O'Rahilly, S.; Turner, R.C.; Matthews, D.R. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N. Engl. J. Med. 1988, 318, 1225-1230.
2. Jakicic, J.M.; Jaramillo, S.A.; Balasubramanyam, A.; Bancroft, B.; Curtis, J.M.; Mathews, A.; Pereira, M.; Regensteiner, J.G.; Ribisl, P.M. Look AHEAD Study Group. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: Results from the Look AHEAD Study. Int. J. Obes. 2009, 33, 305-316.
3. Mozaffarian, D.; Kamineni, A.; Carnethon, M.; Djousse, L.; Mukamal, K.J.; Siscovick, D. Lifestyle risk factors and new-onset diabetes mellitus in older adults: The cardiovascular health study. Arch. Intern. Med. 2009, 169, 798-807.
4. Petro, A.E.; Cotter, J.; Cooper, D.A.; Peters, J.C.; Surwit, S.J.; Surwit, R.S. Fat, carbohydrate and calories in the development of diabetes and obesity in the C57BL/6J mouse. Metabolism 2004, 53, 454-457.
5. Editorial Committee of the Flora of Taiwan; Davallia, S. Flora of Taiwan, 2nd ed.; National Taiwan University: Taipei, Taiwan, 1994; p. 8.
6. Lin, Y.Y.; Kakisawa, H.; Shiobara, Y.; Nakanishi, K. The structure of Davallic acid. Chem. Pharm. Bull. 1965, 13, 986-995.
7. Hwang, T.H.; Kashiwada, Y.; Nonaka, G.I.; Nishioka, I. Flavan-3-ol and proanthocyanidin allosides from Davallia divaricata. Phytochemistry 1989, 28, 891-896.
8. Molinuevo, M.S.; Schurman, L.; McCarthy, A.D.; Cortizo, A.M.; Tolosa, M.J.; Gangoiti, M.V.; Arnol, V.; Sedlinsky, C. Efect of metformin on bone marrow progenitor cell differentiation: In vivo and in vitro studies. J. Bone Miner. Res. 2010, 25, 211-221.
9. Wongdee, K.; Charoenphandhu, N. Osteoporosis in diabetes mellitus: Possible cellular and molecular mechanisms. World J. Diabetes 2011, 2, 41-48.
10. Kim, S.H.; Choung, S.Y. Antihyperglycemic and antihyperlipidemic action of Cinnamomi Cassiae (cinnamon bark) extract in C57BL/Ks db/db mice. Arch. Pharm. Res. 2010, 33, 325-333.
11. Huang, S.; Czech, M.P. The GLUT4 glucose transporter. Cell Metab. 2007, 5, 237-252.
12. Bryant, N.J.; Govers, R.; James, D.E. Regulated transport of the glucose transporter GLUT4. Nat. Rev. Mol. Cell Biol. 2002, 3, 267-277.
13. Holmes, B.; Dohm, G.L. Regulation of GLUT4 gene expression during exercise. Med. Sci. Sports Exerc. 2004, 36, 1202-1206.
14. Sriwijitkamol, A.; Coletta, D.K.; Wajcberg, E., Balbontin, G.B.; Reyna, S.M.; Barrientes, J.; Eagan, P.A.; Jenkinson, C.P.; Cersosimo, E.; DeFronzo, R.A.; et al. Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: A time-course and dose-response study. Diabetes 2007, 56, 836-848.
15. Mackenzie, R.W.; Elliot, B.T. Akt/PKB activation and insulin signaling: A novel insulin signaling pathway in the treatment of type 2 diabetes. Diabetes Metab. Syndr. Obes. 2014, 7, 55-64.
16. Jing, M.; Cheruvu, V.K.; Ismail-Beigi, F. Stimulation of glucose transport in response to activation of distinct AMPK signaling pathways. Am. J. Physiol. Cell Physiol. 2008, 295, C1071-C1082.
17. Zhou, G.; Myers, R.; Li, Y.; Chen, Y.; Shen, X.; Fenyk-Melody, J.; Wu, M.; Ventre, J.; Doebber, T.; Fujii N.; et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Investig. 2001, 108, 1167-1174.
18. Yu, S.; Matsusue, K.; Kashireddy, P.; Cao, W.Q.; Yeldandi, V.; Yeldandi, A.V.; Rao, M.S.; Gonzalez, F.J.; Reddy, J.K. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor γ1 (PPARγ1) overexpression. Biol. Chem. 2003, 278, 498-505.
19. Yki-Jȁrvinen, H. Thiazolidines. N. Engl. J. Med. 2004, 351, 1106-1118.
20. Martinez, L.; Berenguer, M.; Bruce, M.C.; Le Marchand-Brustel, Y.; Govers, R. Rosiglitazone increases cell surface GLUT4 levels in 3T3-L1 adipocytes through an enhancement of endosomal recycling. Biochem. Pharmacol. 2010, 79, 1300-1309.
21. Damci, T.; Tatliagac, S.; Osar, Z.; Ilkova, H. Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia. Eur. J. Intern. Med. 2003, 14, 357-360.
22. Farnier, M.; Bonnefous, F.; Debbas, N.; Irvine, A. Comparative efficacy and safety of micronised fenofibrate and simvastatin in patients with primary type Ha or IIb hyperlipidemia. Arch. Intern. Med. 1994, 154, 441-449.
23. Hsu, S.C.; Huang, C.J. Reduced fat mass in rats fed a high oleic acid-rich safflower oil diet is associated with changes in expression of hepatic PPARα and adipose SREBP-1c-regulated genes. J. Nutr. 2006, 136, 1779-1785.
24. Srivastava, R.A.K.; Jahagirdar, R.; Azhar, S.; Sharma, S.; Bisgaier, C.L. Peroxisome proliferator-activated receptor-α selective ligand reduces adiposity, improves insulin sensitivity, and inhibits atherosclerosis in LDL receptor-deficient mice. Mol. Cell. Biochem. 2006, 285, 35-50.
25. Fryer, L.G.; Parbu-Patel, A.; Patel, A. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 2002, 277, 25226-25232.
26. Ahmed, M.H.; Byrne, C.D. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). Drug Discov. Today 2007, 12, 740-747.
27. Stein, S.C.; Woods, A.; Jones, N.A.; Davison, M.D.; Carling, D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem. J. 2000, 345, 437-443.
28. Kleiner, D.E.; Brunt, E.M.; van Natta, M.; Sanyal, A.J. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41, 1313-1321.
29. Harte, R.A.; Kirk, E.A.; Rosenfeld, M.E.; LeBoeuf, R.C. Initiation of hyperinsulinemia and hyperleptinemia is diet dependent in C57BL/6 mice. Horm. Metab. Res. 1999, 31, 570-575.
30. Guo, S. Insulin signaling, resistance, and metabolic syndrome: Insights from mouse models into disease mechanisms. J. Endocrinol. 2014, 220, T1-T23.
31. Zhu, W.; Cheng, K.K.; Vanhoutte, P.M.; Lam, K.S.; Xu, A. Vascular effects of adiponectin: Molecular mechanisms and potential therapeutic intervention. Clin. Sci. 2008, 114, 361-374.
32. Welsh, G.I.; Hers, I.; Berwick, D.C.; Dell, G.; Wherlock, M.; Birkin, R.; Leney, S.; Tavaré, J.M. Role of protein kinase B in insulin-regulated glucose uptake. Biochem. Soc. Trans. 2005, 33, 346-349.
33. Barthel, A.; Schmoll, D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am. J. Physiol. Endocrinol. Metab. 2003, 285, E685-E692.
34. O'Brien, R.M.; Printz, R.L.; Halmi, N.; Tiesinga, J.J.; Granner, D.K. Structural and functional analysis of the human phosphoenolpyruvate carboxykinase gene promoter. Biochim. Biophys. Acta 1995, 1264, 284-288.
35. Sutherland, C.; O'Brien, R.M.; Granner, D.K. New connections in the regulation of PEPCK gene expression by insulin. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1996, 351, 191-199.
36. Kim, Y.D.; Park, K.G.; Lee, Y.S.; Park, Y.Y.; Kim, D.K.; Nedumaran, B.; Jang, W.G.; Cho, W.J.; Ha, J.; Lee, I.K.; et al. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 2008, 57, 306-314.
37. Koeilevtsev, Y.; Holmes, M.C.; Burchell, A.; Houston, P.M.; Schmoll, D.; Jamieson, P.; Best, R.; Brown, R.; Edwards, C.R.; Seckl, J.R.; et al. 11β-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl. Acad. Sci. USA 1997, 94, 14924-14929.
38. Cases, S.; Smith, S.J.; Zheng, Y.W.; Myers, H.M.; Lear, S.R.; Sande, E.; Novak, S.; Collin, C.; Welch, C.B.; Lusis, A.J.; et al. Identification of a gene encoding an acyl CoA: Diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc. Natl. Acad. Sci. USA 1998, 95, 13018-13023.
39. Oelkers, P.; Behari, A.; Cromley, D.; Billheimer, J.T.; Sturley, S.L. Characterization of two human genes encoding acyl coenzyme A: Cholesterol acyltransferase-related enzymes. J. Biol. Chem. 1998, 273, 26765-26771.
40. Stone, S.J.; Levin, M.C.; Zhou, P.; Han, J.; Walther, T.C.; Farese, R.V., Jr. The endoplasmic reticulum enzyme DGAT2 is found in mitochondria-associated membranes and has a mitochondrial targeting signal that promotes its association with mitochondria. J. Biol. Chem. 2009, 284, 5352-5361.
41. Meegalla, R.L.; Billheimer, J.T.; Cheng, D. Concerted elevation of acyl-coenzyme A: Diacylglycerol acyltransferase (DGAT) activity through independent stimulation of mRNA expression of DGAT1 and DGAT2 by carbohydrate and insulin. Biochem. Biophys. Res. Commun. 2002, 298, 317-323.
42. Yen, C.L.; Stone, S.J.; Koliwad, S.; Harris, C.; Farese, R.V., Jr. Thematic Review Series: Glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J. Lipid Res. 2008, 49, 2283-2301.
43. Lewin, T.M.; Granger, D.A.; Kim, J.H.; Coleman, R.A. Regulation of mitochondrial sn-glycerol-3-phosphate acyltransferase activity: Response to feeding status is unique in various rat tissues and is discordant with protein expression. Arch. Biochem. Biophys. 2001, 396, 119-127.
44. Hotta, K.; Funahashi, T.; Arita, Y.; Takahashi, M.; Matsuda, M.; Okamoto, Y.; Iwahashi, H.; Kuriyama, H.; Ouchi, N.; Maeda, K.; et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 1595-1599.
45. Wu, X.; Motoshima, H.; Mahadev, K.; Stalker, T.J.; Scalia, R.; Goldstein, B.J. Involvement of AMP-activated protein kinase in glucose uptake stimulated by globular domain of adiponectin in primary rat adipocytes. Diabetes 2003, 52, 1355-1363.
46. Minokoshi, Y.; Kim, Y.-B.; Kahn, B.B. Leptin stimulates fatty acid oxidation directly in white adipose tissue through activation of AMP-activated protein kinase. Diabetes 2002, 51, 1375.
47. Rommel, C.; Bodine, S.C.; Clarke, B.A.; Rossman, R.; Nunez, L.; Stitt, T.N.; Yancopoulos, G.D.; Glass, D.J. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)/Akt/GSK3 pathways. Nat. Cell Biol. 2001, 3, 1009-1013.
48. Izumiya, Y.; Hopkins, T.; Morris, C.; Sato, K.; Zeng, L.; Viereck, J.; Hamilton, J.A.; Ouchi, N.; LeBrasseur, N.K.; Walsh, K. Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab. 2008, 7, 159-172.
49. George, S.; Rochford, J.J.; Wolfrum, C.; Gray, S.L.; Schinner, S.; Wilson, J.C.; Soos, M.A.; Murgatroyd, P.R.; Williams, R.M.; Acerini, C.L.; et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 2004, 304, 1325-1328.
50. Ko, Y.J.; Wu, J.B.; Ho, H.Y.; Lin, W.C. Antiosteoporotic activity of Davallia formosana. J. Ethnopharmacol. 2012, 139, 558-565.
51. Li, F.; Xiong, F.M.; Li, X.; Lin, H. Stimulative activity of Drynaria fortune (Kunez) J. Sm. Extracts and two of its flavonoids on the proliferation of osteoblastic like cells. Pharmazie 2006, 61, 962-965.
52. Kuo, Y.H.; Lin, C.H.; Shih, C.C. Ergostatrien-3β-ol from Antrodia camphorata inhibits diabetes and hyperlipidemia in high-fat-diet treated mice via regulation of hepatic related genes, glucose transporter 4, and AMP-Activated protein kinase phosphorylation. J. Agric. Food Chem. 2015, 63, 2479-2489.
53. Shih, C.C.; Shlau, M.T.; Lin, C.H.; Wu, J.B. Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice. Phytother. Res. 2014, 28, 363-371.
54. Shih, C.C.; Lin, C.H.; Wu, J.B. Eriobotrya japonica improves hyperlipidaemia and reverses insulin resistance in high-fat-fed mice. Phytother. Res. 2010, 24, 1769-1780.
55. Shih, C.C.; Ciou, J.L.; Lin, C.H.; Wu, J.B.; Ho, H.Y. Cell suspension culture of Eriobotrya japonica regulates the diabetic and hyperlipidemic signs of high-fat-fed mice. Molecules 2013, 18, 2726-2753.
56. Lin, C.H.; Kuo, Y.H.; Shih, C.C. Effects of Bofu-tsusho-san on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice. Int. J. Mol. Sci. 2014, 15, 20022-20044.
57. Wu, J.B.; Kuo, Y.H.; Lin, C.H.; Ho, Y.H.; Shih, C.C. Tormentic acid, a major component of suspension cells of Eriobotrya japonica, suppresses high-fat diet-induced diabetes and hyperlipidemia by glucose transporter 4 and AMP-activated protein kinase phosphorylation. J. Agric. Food Chem. 2014, 62, 10717-10726.
58. Shih, C.C.; Lin, C.H.; Lin, W.L.; Wu, J.B. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats. J. Ethnopharmacol. 2009, 123, 82-90.